Scroll Top
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Related Posts
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Related Posts
Data Showcases Promising Mechanism of Action of GT-02287 for Parkinson Disease
NeurologyLive
Related Posts
Post navigation
Previous Post
Public Ventures Discovery Day with Eric Richman
Next Post
Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update
Latest Articles
Clear Filters
August 8, 2022
Gain Therapeutics, Inc. Reports Second Quarter 2022 Financial Results and Business Update
Read More
March 15, 2022
AD/PD™ 2022 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders
Read More
March 29, 2022
Cantor Rare Orphan Disease Summit
Read More
Close
